Literature DB >> 15733795

Magnetic resonance spectroscopy study of proton metabolite level changes in sensorimotor cortex after upper limb replantation-revascularization.

Kadir Ertem1, Alpay Alkan, Kaya Sarac, Cagatay Onal, Haci Bostan, Saim Yologlu, Arslan Bora.   

Abstract

We aimed to investigate the changes in proton metabolite levels at the motor and somatosensory cortex by magnetic resonance spectroscopy (MRS) after upper extremity replantation or revascularization. Nine patients who referred to our clinic suffering from major total (two) and subtotal (seven) amputation of the upper extremity were enrolled in this study. Mean time value between the injury and operation was 5.1 h. Mean follow-up period or mean time between the injury and MRS analysis was 26.2 months (ranging from 7 to 41 months). Voxels (TR: 2000; TE: 136 ms) were placed onto locations in the bilateral precentral and postcentral cortex area of the cerebral hemispheres that represent the upper extremity. Contralateral sides of the brain hemisphere that represent the injured extremity were accounted as control groups. Metabolite ratios [NAA (N-acetyl aspartate)/Cr (creatine) and Cho (choline)/Cr] of the motor and somatosensory cortex were calculated. The NAA/Cr and Cho/Cr metabolite ratios between the two groups were found to be insignificant, and these results may indicate that there is no remarkable somatosensorial cortex disruption or demyelination in these patients. Fifty-six percent of patients were found as functional according to Chen's scale.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15733795     DOI: 10.1016/j.mri.2004.11.003

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  1 in total

1.  Magnetic resonance spectroscopy of current hand amputees reveals evidence for neuronal-level changes in former sensorimotor cortex.

Authors:  Carmen M Cirstea; In-Young Choi; Phil Lee; Huiling Peng; Christina L Kaufman; Scott H Frey
Journal:  J Neurophysiol       Date:  2017-02-08       Impact factor: 2.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.